2020: Tromboz, Gemostaz I Reologiya. — 2020. — N4

Review

Tatiana M. Reshetnyak, Fariza А. Cheldieva, Kamila S. Nurbaeva, Alexander M. Lila, Evgeny L. Nasonov

4-21

Antiphospholipid syndrome: diagnosis, development, therapy: 616-005.6:616.151.5:612.115.3

Stanislav Е. Rabotinskiy

22-30

Hemorrhagic syndrome and complement system: is there a connection? 616-002.151

Sergey I. Kusnetsov, Eugene A. Shestakov, Eugene B. Zhiburt

31-34

Coagulopathy in COVID‐19 infection: 616.411-003.971

Original papers

Olga V. Sirotkina, Alexey I. Ermakov, Larisa B. Gaykovaya, Dmitry A. Kudlay, Tatyana V. Vavilova

35-40

Microparticles of blood cells in patients with COVID‐19 as a marker of hemostasis activation: 616.15–008.1

Eugene P. Kharchenko

41-51

The complexity of coagulopathy pathogenesis in COVID‐19: 616–005.6:616.151.5

Olesya Yu. Matvienko, Natalya E. Korsakova, Anna A. Lerner, Tamara N. Shvedova, Ludmila P. Papayan

52-56

Plasma hemostasis in patients with coronavirus infection caused by SARS-CoV-2: 616.151.5:616.988.7

Eugene V. Roitman, Andrey Yu. Bulanov, Valery M. Pechennikov

57-67

Low molecular weight heparins dosing and anti-factor Xa activity in patients with novel coronavirus infection COVID-19: 616.151.511:616-08-035

Igor V. Kurtov, Yuliya O. Berman, Natalia A. Nikulina, Yuliya V. Kuznetsova, Igor L. Davydkin

68-70

The opportunity of dipyridamole using for nonspecific primary prophylaxis against the COVID‐19 infection in healthcare staff: 616.084

Dmitry V. Yudin, Elena M. Shulutko, Valeria V. Valetova, Alexander V. Savushkin, Roksana S. Dubrovina

71-77

The choice among thromboelastometry tests to assess effects of low molecular weight heparins administered in prevention doses: 616–71:616–005

Ruslan I. Sadov, Irina A. Panova, Sergei B. Nazarov, Galina N. Kuzmenko, Irina G. Popova, Natalia V. Kharlamova

78-86

The features of secretory activity of platelets and fibrinolysis in women with various types of hypertensive disorders in the third trimester of pregnancy: 618.3-06:616.12-008.331.1:616.151.5

Mariya G. Nikolaeva, Andrey P. Momot, Andrey N. Mamaev, Nikolay G. Khorev, Natalia M. Pasman, Yulia N. Vagner, Marina S. Zainulina, Ildar F. Fatkullin, Mariya M. Sirazitdinova, Natalia N. Yasafova

87-94

Thrombotic events in rare kinds of genetic thrombophilias: 616.15-008.1

Nadya M. Antonova , Ivan M. Ivanov, Ursula B. Windberger, Vasilka K. Paskova

95-101

Comparative study of blood coagulation kinetics and thrombus formation by rheological and electrorheological methods: 616.151.4:57.013

Alexey V. Lyanguzov, Svetlana L. Kalinina, Sergey V. Ignatyev, Irina A. Dokshina, Andrey Yu. Bulanov, Natalia V. Minaeva, Igor V. Paramonov

102-108

Viscoelastic properties of a blood clot and the manifestations of hemorrhagic syndrome in thrombocytopeniс patients with hemoblastosis: 616.155.02-006.4:616-005.1-08

Clinical cases

Irina A. Lapina, Julia E. Dobrokhotova, Vladislav V. Taranov, Tatiana G. Chirvon

109-113

Anticoagulant management for pregnant women with coronavirus infection: 618.3–06:616.151.5

Georgiy V. Mishin, Vladimir Yu. Zorenko, Evgenii E. Karpov, Nadezda V. Sadykova, Magomet S. Sampiev, Tatyana Yu. Polyanskaya

114-120

The using of modular system (mega prosthesis) for hip, femur, and knee replacement in patient with severe hemophilia A: 617.3/617-089.844/616.151.514-056.7